|
1
|
The Editorial Board of the Cancer
Statistics in Japan: Cancer Statistics in Japan 2012. Foundation
for Promotion of Cancer Research; Tokyo, Japan: 2012
|
|
2
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ellis LM and Fidler IJ: Angiogenesis and
metastasis. Eur J Cancer. 32A:2451–2460. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
5
|
Brizel DM, Scully SP, Harrelson JM,
Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW: Tumor
oxygenation predicts for the likelihood of distant metastases in
human soft tissue sarcoma. Cancer Res. 56:941–943. 1996.PubMed/NCBI
|
|
6
|
Theodoropoulos VE, Lazaris AC, Sofras F,
Gerzelis I, Tsoukala V, Ghikonti I, Manikas K and Kastriotis I:
Hypoxia-inducible factor 1 alpha expression correlates with
angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol.
46:200–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sundfør K, Lyng H and Rofstad EK: Tumour
hypoxia and vascular density as predictors of metastasis in
squamous cell carcinoma of the uterine cervix. Br J Cancer.
78:822–827. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Walenta S, Wetterling M, Lehrke M,
Schwickert G, Sundfør K, Rofstad EK and Mueller-Klieser W: High
lactate levels predict likelihood of metastases, tumor recurrence
and restricted patient survival in human cervical cancers. Cancer
Res. 60:916–921. 2000.PubMed/NCBI
|
|
9
|
Walenta S, Salameh A, Lyng H, Evensen JF,
Mitze M, Rofstad EK and Mueller-Klieser W: Correlation of high
lactate levels in head and neck tumors with incidence of
metastasis. Am J Pathol. 150:409–415. 1997.PubMed/NCBI
|
|
10
|
Pitson G, Fyles A, Milosevic M, Wylie J,
Pintilie M and Hill R: Tumor size and oxygenation are independent
predictors of nodal diseases in patients with cervix cancer. Int J
Radiat Oncol Biol Phys. 51:699–703. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Papandreou I, Cairns RA, Fontana L, Lim AL
and Denko NC: HIF-1 mediates adaptation to hypoxia by actively
downregulating mitochondrial oxygen consumption. Cell Metab.
3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: A metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giaccia A, Siim BG and Johnson RS: HIF-1
as a target for drug development. Nat Rev Drug Discov. 2:803–811.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okamoto K, Ito D, Miyazaki K, Watanabe S,
Tohyama O, Yokoi A, Ozawa Y, Asano M, Kawamura T, Yamane Y, et al:
Microregional antitumor activity of a small-molecule
hypoxia-inducible factor 1 inhibitor. Int J Mol Med. 29:541–549.
2012.PubMed/NCBI
|
|
15
|
Welsh S, Williams R, Kirkpatrick L,
Paine-Murrieta G and Powis G: Antitumor activity and
pharmacodynamic properties of PX-478, an inhibitor of
hypoxia-inducible factor-1alpha. Mol Cancer Ther. 3:233–244.
2004.PubMed/NCBI
|
|
16
|
Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC,
Kim MS and Park JW: YC-1: A potential anticancer drug targeting
hypoxia-inducible factor 1. J Natl Cancer Inst. 95:516–525. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee K, Kang JE, Park SK, Jin Y, Chung KS,
Kim HM, Lee K, Kang MR, Lee MK, Song KB, et al: LW6, a novel HIF-1
inhibitor, promotes proteasomal degradation of HIF-1alpha via
upregulation of VHL in a colon cancer cell line. Biochem Pharmacol.
80:982–989. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Gao P, Fukuda R, Kumar G,
Krishnamachary B, Zeller KI, Dang CV and Semenza GL: HIF-1 inhibits
mitochondrial biogenesis and cellular respiration in VHL-deficient
renal cell carcinoma by repression of C-MYC activity. Cancer Cell.
11:407–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee K, Ban HS, Naik R, Hong YS, Son S, Kim
BK, Xia Y, Song KB, Lee HS and Won M: Identification of malate
dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6
using chemical probes. Angew Chem Int Ed Engl. 52:10286–10289.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Fiskum G and Schubert D: Generation
of reactive oxygen species by the mitochondrial electron transport
chain. J Neurochem. 80:780–787. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yeo EJ, Ryu JH, Chun YS, Cho YS, Jang IJ,
Cho H, Kim J, Kim MS and Park JW: YC-1 induces S cell cycle arrest
and apoptosis by activating checkpoint kinases. Cancer Res.
66:6345–6352. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H
and Liu N: Effects of YC-1 on hypoxia-inducible factor 1-driven
transcription activity, cell proliferative vitality and apoptosis
in hypoxic human pancreatic cancer cells. Pancreas. 34:242–247.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen D, Li M, Luo J and Gu W: Direct
interactions between HIF-1 alpha and Mdm2 modulate p53 function. J
Biol Chem. 278:13595–13598. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hansson LO, Friedler A, Freund S, Rudiger
S and Fersht AR: Two sequence motifs from HIF-1alpha bind to the
DNA-binding site of p53. Proc Natl Acad Sci USA. 99:10305–10309.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kothari S, Cizeau J, McMillan-Ward E,
Israels SJ, Bailes M, Ens K, Kirshenbaum LA and Gibson SB: BNIP3
plays a role in hypoxic cell death in human epithelial cells that
is inhibited by growth factors EGF and IGF. Oncogene. 22:4734–4744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vande Velde C, Cizeau J, Dubik D, Alimonti
J, Brown T, Israels S, Hakem R and Greenberg AH: BNIP3 and genetic
control of necrosis-like cell death through the mitochondrial
permeability transition pore. Mol Cell Biol. 20:5454–5468. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Akakura N, Kobayashi M, Horiuchi I, Suzuki
A, Wang J, Chen J, Niizeki H, Kawamura Ki, Hosokawa M and Asaka M:
Constitutive expression of hypoxia-inducible factor-1alpha renders
pancreatic cancer cells resistant to apoptosis induced by hypoxia
and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.PubMed/NCBI
|
|
29
|
Tait SW and Green DR: Mitochondria and
cell death: Outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View
Article : Google Scholar : PubMed/NCBI
|
